Emcure IPO: Subscription At 63%, Check Latest GMP – Benzinga India

Emcure IPO: Subscription At 63%, Check Latest GMP  Benzinga IndiaNamita Thapar Will Get 293-Fold Return On Her Investment From This IPO  NDTVEmcure Pharma IPO fully subscribed on Day 1 of offer  The Indian ExpressSubscribe for Long Term Emcure Pharmaceuticals Ltd; Motilal Oswal  MoneycontrolEmcure Pharma IPO: Issue fully subscribed on day 1; check subscription status, GMP and other details | Stock Market News  Mint Emcure IPO: Subscription At 63%, Check Latest GMP  Benzinga IndiaNamita Thapar Will Get 293-Fold Return On Her Investment From This IPO  NDTVEmcure Pharma IPO fully subscribed on Day 1 of offer  The Indian ExpressSubscribe for Long Term Emcure Pharmaceuticals Ltd; Motilal Oswal  MoneycontrolEmcure Pharma IPO: Issue fully subscribed on day 1; check subscription status, GMP and other details | Stock Market News  Mint  Top stories – Google News